The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Hepatoma cell‐secreted exosomal microRNA‐103 increases vascular permeability and promotes metastasis by targeting junction proteins
Abstract
Increased vascular permeability facilitates metastasis. Emerging evidence indicates that secreted microRNAs (miRNAs) may mediate the crosstalk between cancer and stromal cells. To date, whether and how secreted miRNAs affect vascular permeability remains unclear. Based on deep sequencing and quantitative PCR, we found that higher level of serum miR‐103 was associated with higher metastasis potential of hepatocellular carcinoma (HCC). The in vitro endothelial permeability and transendothelial invasion assays revealed that the conditioned media or exosomes derived from high miR‐103‐expressing hepatoma cells increased the permeability of endothelial monolayers, but this effect was attenuated if exosome secretion of hepatoma cells was blocked by silencing ALIX and HRS or if miR‐103 within hepatoma or endothelial cells was antagonized. Most importantly, pretreating endothelial monolayers with exosomes that were from stable miR‐103‐expressing hepatoma cells facilitated the transendothelial invasion of tumor cells, and this role of exosomes was abrogated by inhibiting miR‐103 in endothelial cells. Further in vivo analyses disclosed that mice with xenografts of stable miR‐103‐expressing hepatoma cells exhibited higher vascular permeability in tumor, higher level of exosomal miR‐103 and greater number of tumor cells in blood circulation, and increased rates of hepatic and pulmonary metastases, compared to control mice. Mechanism investigations revealed that hepatoma cell‐secreted miR‐103 could be delivered into endothelial cells via exosomes, and then attenuated the endothelial junction integrity by directly inhibiting the expression of VE‐Cadherin (VE‐Cad), p120‐catenin (p120) and zonula occludens 1. Moreover, miR‐103 could also promote tumor cell migration by repressing p120 expression in hepatoma cells. Conclusion: Hepatoma cell‐secreted exosomal miR‐103 increases vascular permeability and promotes tumor metastasis by targeting multiple endothelial junction proteins, which highlights secreted miR‐103 as a potential therapeutic target and a predictive marker for HCC metastasis. (H epatology 2018).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rupaimoole, R., & Slack, F. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.246 · Cited by 4,741 · cited 1×
“Dysfunction of miRNAs is implicated in different pathological processes, especially in cancer development.((11)) Emerging evidence shows that miRNAs can be actively secreted and delivered into recipient cells, where they block the translation of target genes and thereby affect the activities of recipient cells.”
BackgroundCancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis
Zhou, W., Fong, M. Y., Min, Y., Somlo, G., Liu, L., Palomares, M. R., Yu, Y., Chow, A., O’Connor, S. T. F., Chin, A. R., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.007 · Cited by 1,476 · cited 8×
“process.((1,3-5)) Cell-to-cell junctions between endothelial cells, which are critical in maintaining vascular integrity, consist of adherens junctions and tight junctions.”
BackgroundMethodInfluentialEndothelial Cell-to-Cell Junctions: Molecular Organization and Role in Vascular Homeostasis
Bazzoni, G., & Dejana, E. (2004) · Physiological Reviews · doi:10.1152/physrev.00035.2003 · Cited by 1,389
Ying, W., Riopel, M., Bandyopadhyay, G., Dong, Y., Birmingham, A., Seo, J. B., Ofrecio, J. M., Wollam, J., Hernandez-Carretero, A., Fu, W., et al. (2017) · Cell · doi:10.1016/j.cell.2017.08.035 · Cited by 1,191 · cited 1×
“The exosomes from the CM of liver cells or hepatoma cells that were grown in DMEM supplemented with 10% exosome-depleted FBS (10% FBS-DMEM) were isolated, and characterized by using transmission electron microscope (JEM-100CX-II, JEOL, Japan), NanoSight analysis (NanoSight NS-300 instrument, Malvern, United Kingdom) a…”
MethodMicroenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth
Zhang, L., Zhang, S., Yao, J., Lowery, F. J., Zhang, Q., Huang, W.-C., Li, P., Li, M., Wang, X., Zhang, C., et al. (2015) · Nature · doi:10.1038/nature15376 · Cited by 1,175
Crossing the endothelial barrier during metastasis
Reymond, N., d'Água, B. B., & Ridley, A. J. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3628 · Cited by 922
Secreted microRNAs: a new form of intercellular communication
Chen, X., Liang, H., Zhang, J., Zen, K., & Zhang, C.-Y. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.12.001 · Cited by 690
A network-biology perspective of microRNA function and dysfunction in cancer
Bracken, C. P., Scott, H. S., & Goodall, G. J. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.134 · Cited by 668
A MicroRNA Targeting Dicer for Metastasis Control
Martello, G., Rosato, A., Ferrari, F., Manfrin, A., Cordenonsi, M., Dupont, S., Enzo, E., Guzzardo, V., Rondina, M., Spruce, T., et al. (2010) · Cell · doi:10.1016/j.cell.2010.05.017 · Cited by 667
Cancer cell motility: lessons from migration in confined spaces
Paul, C. D., Mistriotis, P., & Konstantopoulos, K. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.123 · Cited by 648
Harney, A. S., Arwert, E. N., Entenberg, D., Wang, Y., Guo, P., Qian, B.-Z., Oktay, M. H., Pollard, J. W., Jones, J. G., & Condeelis, J. S. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0012 · Cited by 618
Su, H., Yang, J.-R., Xu, T., Huang, J., Xu, L., Yuan, Y., & Zhuang, S.-M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2886 · Cited by 612
Self-citationUmezu, T., Tadokoro, H., Azuma, K., Yoshizawa, S., Ohyashiki, K., & Ohyashiki, J. H. (2014) · Blood · doi:10.1182/blood-2014-05-576116 · Cited by 600
Kogure, T., Lin, W.-L., Yan, I. K., Braconi, C., & Patel, T. (2011) · Hepatology · doi:10.1002/hep.24504 · Cited by 551
Ishiyama, N., Lee, S.-H., Liu, S., Li, G.-Y., Smith, M. J., Reichardt, L. F., & Ikura, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.017 · Cited by 357
Fang, J.-H., Zhou, H.-C., Zeng, C., Yang, J., Liu, Y., Huang, X., Zhang, J.-P., Guan, X.-Y., & Zhuang, S.-M. (2011) · Hepatology · doi:10.1002/hep.24577 · Cited by 307
Self-citationChen, H.-Y., Lin, Y.-M., Chung, H.-C., Lang, Y.-D., Lin, C.-J., Huang, J., Wang, W.-C., Lin, F.-M., Chen, Z., Huang, H.-D., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0667 · Cited by 303
Self-citationEndothelial destabilization by angiopoietin-2 via integrin β1 activation
Hakanpaa, L., Sipila, T., Leppanen, V.-M., Gautam, P., Nurmi, H., Jacquemet, G., Eklund, L., Ivaska, J., Alitalo, K., & Saharinen, P. (2015) · Nature Communications · doi:10.1038/ncomms6962 · Cited by 287
Lin, X.-J., Chong, Y., Guo, Z.-W., Xie, C., Yang, X.-J., Zhang, Q., Li, S.-P., Xiong, Y., Yuan, Y., Min, J., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00048-0 · Cited by 276
Self-citationChen, L., Charrier, A., Zhou, Y., Chen, R., Yu, B., Agarwal, K., Tsukamoto, H., Lee, J. L., Paulaitis, M. E., & Brigstock, D. R. (2014) · Hepatology · doi:10.1002/hep.26768 · Cited by 264
Fang, J., Zhou, H., Zhang, C., Shang, L., Zhang, L., Xu, J., Zheng, L., Yuan, Y., Guo, R., Jia, W., et al. (2015) · Hepatology · doi:10.1002/hep.27760 · Cited by 256
Self-citationKleivi Sahlberg, K., Bottai, G., Naume, B., Burwinkel, B., Calin, G. A., Børresen-Dale, A.-L., & Santarpia, L. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2011 · Cited by 228
Sato, K., Meng, F., Glaser, S., & Alpini, G. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.03.004 · Cited by 186
Wei, J., Lv, L., Wan, Y., Cao, Y., Li, G., Lin, H., Zhou, R., Shang, C., Cao, J., He, H., et al. (2015) · Hepatology · doi:10.1002/hep.27660 · Cited by 169
VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread
Li, X., Padhan, N., Sjöström, E. O., Roche, F. P., Testini, C., Honkura, N., Sáinz-Jaspeado, M., Gordon, E., Bentley, K., Philippides, A., et al. (2016) · Nature Communications · doi:10.1038/ncomms11017 · Cited by 149 · cited 3×
“Increased vascular permeability, a characteristic of tumor vessels, facilitates metastasis.((1,3-5)) The reason that tumor vessels displayed higher permeability is unclear.”
BackgroundVinyoles, M., del Valle‐Pérez, B., Curto, J., Viñas-Castells, R., Alba‐Castellón, L., de Herreros, A. G., & Duñach, M. (2014) · Molecular Cell · doi:10.1016/j.molcel.2013.12.010 · Cited by 127
Ding, Z., Jin, G.-N., Wang, W., Chen, W., Wu, Y., Ai, X., Chen, L., Zhang, W., Liang, H., Laurence, A. D. J., et al. (2014) · Hepatology · doi:10.1002/hep.27273 · Cited by 125
MicroRNA-Containing T-Regulatory-Cell-Derived Exosomes Suppress Pathogenic T Helper 1 Cells
Okoye, I., Coomes, S. M., Pelly, V. S., Czieso, S., Papayannopoulos, V., Tolmachova, T., Seabra, M. C., & Wilson, M. S. (2014) · Immunity · doi:10.1016/j.immuni.2014.08.008 · Cited by 116
Basu, S., & Bhattacharyya, S. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku346 · Cited by 84
VEGF165-induced vascular permeability requires NRP1 for ABL-mediated SRC family kinase activation
Fantin, A., Λαμπροπούλου, Α., Senatore, V., Brash, J. T., Prahst, C., Lange, C., Liyanage, S. E., Raimondi, C., Bainbridge, J. W., Augustin, H. G., et al. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20160311 · Cited by 68
Jiang, L., Yan, Q., Fang, S., Liu, M., Li, Y., Yuan, Y., Li, Y., Zhu, Y., Qi, J., Yang, X., et al. (2017) · Hepatology · doi:10.1002/hep.29312 · Cited by 51
Self-citationMicroRNA-103 suppresses tumor cell proliferation by targeting PDCD10 in prostate cancer
Fu, X., Zhang, W., Su, Y., Lu, L., Wang, D., & Wang, H. (2016) · The Prostate · doi:10.1002/pros.23143 · Cited by 48
p120 Catenin-Mediated Stabilization of E-Cadherin Is Essential for Primitive Endoderm Specification
Pieters, T., Goossens, S., Haenebalcke, L., Andries, V., Stryjewska, A., Rycke, R. M. D., Lemeire, K., Hochepied, T., Huylebroeck, D., Berx, G., et al. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006243 · Cited by 33
Angiopoietin‐2 mediates thrombin‐induced monocyte adhesion and endothelial permeability
Rathnakumar, K., Savant, S., Giri, H., Ghosh, A., Fisslthaler, B., Fleming, I., Ram, U., Bera, A. K., Augustin, H. G., & Dixit, M. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13376 · Cited by 27
Cited by
Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT
Zhang, X., Sai, B., Wang, F., Wang, L., Wang, Y., Zheng, L., Li, G., Tang, J., & Xiang, J. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0959-5 · Cited by 560
MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases
Wang, X., He, Y., Mackowiak, B., & Gao, B. (2021) · Gut · doi:10.1136/gutjnl-2020-322526 · Cited by 495
The significance of exosomes in the development and treatment of hepatocellular carcinoma
Li, X., Li, C., Zhang, L., Wu, M., Cao, K., Jiang, F., Chen, D., Li, N., & Li, W. (2020) · Molecular Cancer · doi:10.1186/s12943-019-1085-0 · Cited by 395
Huang, X.-Y., Huang, Z.-L., Huang, J., Xu, B., Huang, X.-Y., Xu, Y.-H., Zhou, J., & Tang, Z.-Y. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-1529-9 · Cited by 395
Exosomal long noncoding RNA LNMAT2 promotes lymphatic metastasis in bladder cancer
Chen, C., Luo, Y., He, W., Zhao, Y., Kong, Y., Liu, H., Zhong, G., Li, Y., Li, J., Huang, J., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci130892 · Cited by 389
Self-citation
Metadata
- Authors
- Fang, J., Zhang, Z., Shang, L., Luo, Y., Lin, Y., Yuan, Y., & Zhuang, S.
- Venue
- Hepatology
- Published
- 2018-07-25
- Volume
- 68
- Issue
- 4
- Pages
- 1459-1475
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W2797968797
- Cited by
- 335
- References
- 34
- FWCI
- 13.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.